US FDA

Thumbnail for FDA clears Zimmer Biomet Knee Implant for metal sensitivity

9 March 2025

FDA clears Zimmer Biomet Knee Implant for metal sensitivity

Thumbnail for Gilead’s Lenacapavir PrEP gets FDA Review

21 February 2025

Gilead’s Lenacapavir PrEP gets FDA Review

Thumbnail for GSK’s Penmenvy gets FDA approval for teens in US

18 February 2025

GSK’s Penmenvy gets FDA approval for teens in US

Thumbnail for Johnson & Johnson’s Spravato gets nod as standalone treatment for depression

24 January 2025

Johnson & Johnson’s Spravato gets nod as standalone treatment for depression

Thumbnail for Calquence receives full FDA approval for first-line treatment of Mantle Cell Lymphoma

23 January 2025

Calquence receives full FDA approval for first-line treatment of Mantle Cell Lymphoma

Thumbnail for Johnson & Johnson submits New Drug Application for TAR-200 to FDA

20 January 2025

Johnson & Johnson submits New Drug Application for TAR-200 to FDA

Thumbnail for Eisai, Biogen move closer to launching more convenient Alzheimer’s treatment

16 January 2025

Eisai, Biogen move closer to launching more convenient Alzheimer’s treatment

Thumbnail for Alembic secures USFDA nod for generic Diltiazem

12 November 2024

Alembic secures USFDA nod for generic Diltiazem

Thumbnail for Zydus Lifesciences receives FDA approval for generic Paliperidone

11 October 2024

Zydus Lifesciences receives FDA approval for generic Paliperidone

Thumbnail for AbbVie submits lung cancer drug Teliso-V for FDA approval

2 October 2024

AbbVie submits lung cancer drug Teliso-V for FDA approval